×
S&P 500   4,143.97 (+2.12%)
DOW   33,089.77 (+1.39%)
QQQ   307.62 (+2.77%)
AAPL   148.77 (+3.47%)
MSFT   270.98 (+1.91%)
FB   194.22 (+1.35%)
GOOGL   2,239.99 (+3.90%)
AMZN   2,282.10 (+2.73%)
TSLA   755.27 (+6.72%)
NVDA   187.55 (+5.06%)
BABA   93.29 (-1.26%)
NIO   16.50 (+2.93%)
AMD   101.90 (+3.19%)
CGC   4.88 (-12.07%)
MU   73.13 (+3.58%)
T   21.21 (-0.52%)
GE   78.24 (+1.60%)
F   13.58 (+3.51%)
DIS   108.96 (+3.17%)
AMC   14.24 (+16.43%)
PFE   53.60 (-0.72%)
PYPL   84.79 (+5.43%)
NFLX   193.81 (+1.26%)
S&P 500   4,143.97 (+2.12%)
DOW   33,089.77 (+1.39%)
QQQ   307.62 (+2.77%)
AAPL   148.77 (+3.47%)
MSFT   270.98 (+1.91%)
FB   194.22 (+1.35%)
GOOGL   2,239.99 (+3.90%)
AMZN   2,282.10 (+2.73%)
TSLA   755.27 (+6.72%)
NVDA   187.55 (+5.06%)
BABA   93.29 (-1.26%)
NIO   16.50 (+2.93%)
AMD   101.90 (+3.19%)
CGC   4.88 (-12.07%)
MU   73.13 (+3.58%)
T   21.21 (-0.52%)
GE   78.24 (+1.60%)
F   13.58 (+3.51%)
DIS   108.96 (+3.17%)
AMC   14.24 (+16.43%)
PFE   53.60 (-0.72%)
PYPL   84.79 (+5.43%)
NFLX   193.81 (+1.26%)
S&P 500   4,143.97 (+2.12%)
DOW   33,089.77 (+1.39%)
QQQ   307.62 (+2.77%)
AAPL   148.77 (+3.47%)
MSFT   270.98 (+1.91%)
FB   194.22 (+1.35%)
GOOGL   2,239.99 (+3.90%)
AMZN   2,282.10 (+2.73%)
TSLA   755.27 (+6.72%)
NVDA   187.55 (+5.06%)
BABA   93.29 (-1.26%)
NIO   16.50 (+2.93%)
AMD   101.90 (+3.19%)
CGC   4.88 (-12.07%)
MU   73.13 (+3.58%)
T   21.21 (-0.52%)
GE   78.24 (+1.60%)
F   13.58 (+3.51%)
DIS   108.96 (+3.17%)
AMC   14.24 (+16.43%)
PFE   53.60 (-0.72%)
PYPL   84.79 (+5.43%)
NFLX   193.81 (+1.26%)
S&P 500   4,143.97 (+2.12%)
DOW   33,089.77 (+1.39%)
QQQ   307.62 (+2.77%)
AAPL   148.77 (+3.47%)
MSFT   270.98 (+1.91%)
FB   194.22 (+1.35%)
GOOGL   2,239.99 (+3.90%)
AMZN   2,282.10 (+2.73%)
TSLA   755.27 (+6.72%)
NVDA   187.55 (+5.06%)
BABA   93.29 (-1.26%)
NIO   16.50 (+2.93%)
AMD   101.90 (+3.19%)
CGC   4.88 (-12.07%)
MU   73.13 (+3.58%)
T   21.21 (-0.52%)
GE   78.24 (+1.60%)
F   13.58 (+3.51%)
DIS   108.96 (+3.17%)
AMC   14.24 (+16.43%)
PFE   53.60 (-0.72%)
PYPL   84.79 (+5.43%)
NFLX   193.81 (+1.26%)

Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast, Price & News

$30.32
-0.05 (-0.16%)
(As of 05/27/2022 02:30 PM ET)
Add
Compare
Today's Range
$30.28
$30.42
50-Day Range
$29.21
$34.41
52-Week Range
$28.75
$42.45
Volume
4,642 shs
Average Volume
507,239 shs
Market Capitalization
$17.77 billion
P/E Ratio
17.33
Dividend Yield
1.62%
Beta
1.17
30 days | 90 days | 365 days | Advanced Chart
Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Fresenius Medical Care AG & Co. KGaA logo

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
122,909
Year Founded
1912

Sales & Book Value

Annual Sales
$20.85 billion
Cash Flow
$5.46 per share
Book Value
$27.84 per share

Profitability

Net Income
$1.15 billion
Pretax Margin
8.11%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$17.77 billion
Optionable
Optionable

Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 5/27 Dividend
5/13/2022
Today
5/27/2022
Dividend Payable
5/27/2022
Next Earnings (Estimated)
7/29/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.08 out of 5 stars

Medical Sector

500th out of 1,424 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

8th out of 16 stocks

Analyst Opinion: 3.0Community Rank: 3.6Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -













Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Frequently Asked Questions

Is Fresenius Medical Care AG & Co. KGaA a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 2 sell ratings, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Fresenius Medical Care AG & Co. KGaA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View analyst ratings for Fresenius Medical Care AG & Co. KGaA
or view top-rated stocks.

Are investors shorting Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,090,000 shares, an increase of 50.6% from the April 30th total of 723,800 shares. Based on an average trading volume of 541,600 shares, the days-to-cover ratio is currently 2.0 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

Fresenius Medical Care AG & Co. KGaA is scheduled to release its next quarterly earnings announcement on Friday, July 29th 2022.
View our earnings forecast for Fresenius Medical Care AG & Co. KGaA
.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its earnings results on Wednesday, May, 4th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.08. The company earned $5.10 billion during the quarter, compared to analyst estimates of $4.97 billion. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 6.99% and a net margin of 4.91%.
View Fresenius Medical Care AG & Co. KGaA's earnings history
.

How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Friday, April 29th. Shareholders of record on Monday, May 16th will be given a dividend of $0.7093 per share on Friday, May 27th. This represents a dividend yield of 3.4%. The ex-dividend date of this dividend is Friday, May 13th.
View Fresenius Medical Care AG & Co. KGaA's dividend history
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.49 per share and currently has a dividend yield of 1.62%. The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 28.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 21.68% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.
View Fresenius Medical Care AG & Co. KGaA's dividend history.

What price target have analysts set for FMS?

11 Wall Street analysts have issued 12-month price targets for Fresenius Medical Care AG & Co. KGaA's stock. Their forecasts range from $30.30 to $83.40. On average, they anticipate Fresenius Medical Care AG & Co. KGaA's share price to reach $53.71 in the next year. This suggests a possible upside of 77.2% from the stock's current price.
View analysts' price targets for Fresenius Medical Care AG & Co. KGaA
or view top-rated stocks among Wall Street analysts.

Who are Fresenius Medical Care AG & Co. KGaA's key executives?
Fresenius Medical Care AG & Co. KGaA's management team includes the following people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Management Board & CEO of Fresenius Medical Care Management AG (Age 67, Pay $3.64M)
  • Ms. Helen Giza, Chief Transformation Officer, CFO & Member of Mgmt Board of Fresenius Medical Care Mgmt AG (Age 54, Pay $1.88M)
  • Dr. Franklin W. Maddux F.A.C.P., Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG (Age 65, Pay $1.68M)
  • Mr. William Valle, Management Board Member for Care Delivery of Fresenius Medical Care Management AG (Age 62, Pay $4.15M)
  • Dr. Katarzyna Mazur-Hofsab Ph.D., Management Board Member for Care Enablement of Fresenius Medical Care Management AG (Age 59, Pay $4.61M)
  • Mr. Roberto Fuste, Exec. Advisor for Regional Strategy (Age 70)
  • Dr. Nwamaka Eneanya M.D., Head of Strategy & Operations
  • Dr. Dominik Heger, Exec. VP and Head of Investor Relations, Strategic Devel. & Communications
  • Mr. Borries Von Muller, Sr. VP of Global HR Employee Communications (Age 61)
  • Mr. Joachim Weith, Sr. VP of Corp. Communications & Gov.al Affairs
What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Fresenius Medical Care AG & Co. KGaA's stock is owned by many different retail and institutional investors. Top institutional shareholders include Pzena Investment Management LLC (1.98%), First Trust Advisors LP (0.32%), Cambiar Investors LLC (0.23%), Tweedy Browne Co LLC (0.18%), Citigroup Inc. (0.11%) and Invesco Ltd. (0.08%).

Which institutional investors are selling Fresenius Medical Care AG & Co. KGaA stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Arrowstreet Capital Limited Partnership, First Trust Advisors LP, Dimensional Fund Advisors LP, BlackRock Inc., Jarislowsky Fraser Ltd, UBS Group AG, and Simplex Trading LLC.

Which institutional investors are buying Fresenius Medical Care AG & Co. KGaA stock?

FMS stock was acquired by a variety of institutional investors in the last quarter, including Pzena Investment Management LLC, Cambiar Investors LLC, Envestnet Asset Management Inc., Invesco Ltd., Clearbridge Investments LLC, Ethic Inc., PEAK6 Investments LLC, and Legacy Wealth Asset Management LLC.

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FMS stock can currently be purchased for approximately $30.32.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA has a market capitalization of $17.77 billion and generates $20.85 billion in revenue each year. The company earns $1.15 billion in net income (profit) each year or $1.75 on an earnings per share basis.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

Fresenius Medical Care AG & Co. KGaA employs 122,909 workers across the globe.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?

The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.

When was Fresenius Medical Care AG & Co. KGaA founded?

Fresenius Medical Care AG & Co. KGaA was founded in 1912.

What is Fresenius Medical Care AG & Co. KGaA's official website?

The official website for Fresenius Medical Care AG & Co. KGaA is www.freseniusmedicalcare.com.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at (496) 172-6090, via email at [email protected], or via fax at 49-6172-609-2301.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.